Browsing Tag
Denali Capital
1 post
Biopharma shake-up: Semnur Pharmaceuticals to merge with Denali Capital in $2.5bn deal
In a significant development within the biopharmaceutical industry, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex…